Sacha Gnjatic

Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma

E. Cerami, D. D. Del Valle, S. Kim-Schulze, 2024, Cancer research communications.

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma

A. Laganà, S. Lonial, M. Dhodapkar, 2024, bioRxiv.

Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond

A. Sonabend, J. Guevara-Patiño, Rebecca C. Obeng, 2024, Cancers.